Association for Accessible Medicines filed 2 comments on this docket between Dec 4, 2017 and Jul 16, 2021. 0 other organizations filed here. The comment window closed 3096d ago.
Comments from The Association for Accessible Medicines (AAM) regarding Docket FDA- 2017-D-5767: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin
The Association for Accessible Medicines (AAM) acknowledges the efforts of the FDA on Docket Number FDA-2017-D-5767 concerning certain highly purified synthetic peptide products. We would also like to thank you for the opportunity to share our thoughts on this important public health issue.
No abstract recorded.
View on regulations.gov →